USP Grade Oncology Drug CAS 19767-45-4 Mesna

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of US$ 1000/kg
Request Sample
Diamond Member Since 2021

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Registered Capital
10000000 RMB
Plant Area
101~500 square meters
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
  • USP Grade Oncology Drug CAS 19767-45-4 Mesna
Find Similar Products

Basic Info.

Model NO.
Mesna
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Elderly, Children, Adult
State
Powder
Purity
>99%
Mf
C2h5nao3s2
MW
164.1791
Type
Antineoplastic Agents
Storage
Cool Dry Place
Shelf Life
24 Months
Transport Package
1kg/Bag, 25kg/Drum
Specification
Mesna
Trademark
HNB
Origin
China
Production Capacity
500kg/Month

Product Description

USP Grade Oncology Drug CAS 19767-45-4 Mesna
Mesna CAS : 19767-45-4 Brand:HNB
MW: C2H5NaO3S2 MSDS: Avaiable
MF : 164.17 Sample: Avaiable
Category: Oncology drug Min order: 10grams
Quality standard:   USP Place of Origin:China
Introduction Mesna is an organosulfur compound. It is used in cancer chemotherapy involving cyclophosphamide and ifosfamide as an adjuvant. It is an acronym for 2-Mercaptoethane sulfonate Na (Na being the symbol for sodium). Mesna is used therapeutically to reduce the incidence of haemorrhagic cystitis and haematuria when a patient receives ifosfamide or cyclophosphamide for cancer chemotherapy. These two anticancer agents, in vivo, may be converted to urotoxic metabolites such as acrolein. It assists to detoxify these metabolites by reaction of its sulfhydryl group with the vinyl group. It also increases urinary excretion of cysteine
Character White to off-white powder
Applications Pharmaceutical raw materials , Oncology drug
 

Indication:

Prevent urinary tract toxicity caused by cyclophosphamide, different cyclophosphamide, chlorine phosphorus amide medicines
Pharmacology:

This product is contained half glutathione amino acid compounds, can repeat activation cyclophosphamide with toxic or the daughter cyclophosphamide metabolites unifies, forming non toxic product which quickly out of body with urine. 
Prevent urinary tract toxicity caused by cyclophosphamide, different cyclophosphamide, chlorine phosphorus amide medicines


USP Grade Oncology Drug CAS 19767-45-4 Mesna
USP Grade Oncology Drug CAS 19767-45-4 MesnaUSP Grade Oncology Drug CAS 19767-45-4 MesnaUSP Grade Oncology Drug CAS 19767-45-4 MesnaUSP Grade Oncology Drug CAS 19767-45-4 MesnaUSP Grade Oncology Drug CAS 19767-45-4 MesnaUSP Grade Oncology Drug CAS 19767-45-4 Mesna

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier